Takeda Pharmaceutical Company Limited New Liabilities Contingent Liabilities Recognised In Business Combination
Takeda Pharmaceutical Company Limited (TKPHF) reported New Liabilities Contingent Liabilities Recognised In Business Combination of JPY 0 for the 12-month period ending 2023-03-31, per its 20-F filed 2023-06-28.
Discontinued › Notes
ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination · last filed 2023-06-28
| Period end | New Liabilities Contingent Liabilities Recognised In Business Combination 12 month |
|---|---|
| 2023-03-31 | 0.00 JPY 20-F · filed 2023-06-28 |
| 2022-03-31 | 5.20B JPY 20-F · filed 2023-06-28 |
| 2021-03-31 | 0.00 JPY 20-F · filed 2022-06-29 |